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Abstract:  20 
Background: Emotional disclosure is the therapeutic expression of emotion. It holds potential as a 21 
means of providing psychological support. However, evidence of its efficacy in palliative settings is 22 
mixed. This may be due to variation in intervention characteristics.   23 
Aim: To derive a greater understanding of the characteristics of potentially effective emotional 24 
disclosure-based interventions in palliative care by: 25 
(1) Developing a taxonomy of emotional disclosure-based interventions tested in people with 26 
advanced disease and 27 
(2) Mapping and linking objectives, outcomes, underlying mechanisms and implementation factors. 28 
Design: A scoping review drawing on Intervention Component Analysis to combine evidence from 29 
studies’ methods, results and discussion sections. 30 
Data sources: Six databases were searched to May 2020 including CINAHL, PsycINFO, and MEDLINE. 31 
Studies of emotional disclosure in adults with advanced disease were included. Study quality was 32 
appraised using an established tool.  33 
Results: 7,792 unique records were screened, of which 25 primary studies were included. 34 
Intervention characteristics were grouped into classes within three domains: topic of disclosure, 35 
format and dose. Evidence was not available to determine which, if any, of the characteristics is 36 
most effective. Thematic synthesis of evidence from methods and discussion sections identified 37 
factors to consider in tailoring an emotional disclosure-based intervention to this setting, including: 38 
population characteristics (e.g., time since diagnosis), providing a safe environment, and flexibility in 39 
format. 40 
Conclusions: This review approach facilitated a clearer understanding of factors that may be key in 41 
developing emotional disclosure interventions for palliative populations. Intervention Component 42 
Analysis has potential for application elsewhere to help develop evidence-based interventions. 43 
 44 
Key words:  45 
Palliative Care, Psychotherapy, Emotions, Mental Health, Scoping Review, Intervention Component 46 
Analysis 47 
 48 
Key statements: 49 
What is already known about the topic? 50 
• Emotional disclosure -based interventions can improve psychological and physical wellbeing in 51 
general populations. 52 
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• A range of emotional disclosure-based interventions exist, but evidence of their efficacy in 53 
palliative care is mixed; it is not clear in which forms they may be effective or most effective, and 54 
on which outcome. 55 
• Trials have been limited in the extent to which they have tailored the intervention for people 56 
with advanced disease. 57 
What this paper adds 58 
• To our knowledge, this is the first scoping review to systematically map the characteristics of 59 
emotional disclosure-based interventions that have been tested in people with advanced 60 
disease. 61 
• By grouping intervention characteristics into classes within operative domains and mapping 62 
these to outcomes, we provide a picture of which intervention forms may be most promising to 63 
pursue in future research. 64 
• Disease stage, environment, flexibility in delivery and topic, clarity of instructions and staff 65 
training are identified as important factors to consider when tailoring emotional disclosure-66 
based interventions for people with advanced disease. 67 
Implications for practice, theory or policy 68 
• The review provides an exemplar approach to scoping literature to inform complex intervention 69 
development and evaluation in cases where pre-existing findings are mixed. 70 
• The review highlights the need for researchers to report key facilitators and barriers they find in 71 
intervention implementation and efficacy when presenting results. 72 
• Researchers should consider the recommendations made in this review to inform development 73 







Introduction  81 
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Psychological distress can be considerable for people living with advanced disease. For up to 50% of 82 
people receiving palliative care, this distress can develop into clinical anxiety or depression (1–4). In 83 
recognition of this, national and international clinical guidelines recommend that psychological 84 
support should form a crucial element of the holistic palliative care approach (5–9). However, research 85 
indicates current psychological service provision in palliative care is likely to be inadequate in the UK 86 
and globally (10–12). This can be partially attributed to limitations in funding for the end-of-life care 87 
sector (12–14). It is therefore important that palliative care services can access and implement cost-88 
effective ways of providing psychological support for people in their care. 89 
Certain forms of emotional disclosure -based interventions offer a potentially promising solution. For 90 
the purposes of this review, emotional disclosure is defined as techniques designed to encourage or 91 
facilitate the disclosure, expression or discussion of emotions or feelings. These therapies are based 92 
on the notion that expressing emotions can improve wellbeing (15). The therapeutic potential of 93 
emotional disclosure has been recognised cross-culturally for centuries in the form of religious 94 
confessions and Freudian psychotherapeutic approaches (15). For example, drawing on this long 95 
history, a simple expressive writing intervention was proposed in 1986 (16). In its most basic format, 96 
it involves writing down the facts and emotions about a trauma for 15-20 minutes per day over 3-4 97 
consecutive days without the need for professional facilitation (17). Hundreds of studies have since 98 
investigated expressive writing and emotional disclosure-based variations, with meta-analyses 99 
reporting small but positive effects on both physical and psychological health in various populations 100 
(18–21).  101 
Trials of emotional disclosure-based interventions in palliative populations, however, have had mixed-102 
results (22–24). A recent meta-analysis of randomised controlled trials (RCTs) of expressive writing in 103 
people with advanced disease found, overall, it had no significant effect on the physical or 104 
psychological health measures investigated (24). However, this evidence is weak; it is from four RCTs 105 
of limited quality, with only one of these using an intervention that had been specifically tailored to 106 
the unique needs of its population (25). Whilst this study did individually report a positive effect of 107 
the intervention, it was a pilot with 13 participants, and thus was not designed to detect significance 108 
(25). The importance of tailoring interventions to the target population is likely to be crucial, given the 109 
unique existential distress and physical challenges experienced by people at this stage of their illness. 110 
As a result, there is still a need for further, robustly designed trials of tailored emotional disclosure-111 
based interventions. 112 
In their guidelines for complex intervention development, the Medical Research Council outline the 113 
importance of having a clear theoretical rationale for an intervention and its component parts (26–114 
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28). A number of processes have been proposed to explain the potential effects of emotional 115 
disclosure, including emotion regulation and the psychosomatic theory of inhibition (29). However, it 116 
is not clear to what extent existing interventions tested in palliative care draw on these processes to 117 
inform their design (29–31). Forming clearer links between underlying processes and intervention 118 
design may also help to inform outcome measure selection. Outside of the advanced disease 119 
populations, reviews have found significant as well as null effects of emotional disclosure-based 120 
interventions on a range of psychological and physical symptoms (18,31,32).  As such, it is not clear 121 
which outcome measures may be most appropriate for evaluating effectiveness. 122 
Moreover, the content and structure of emotional disclosure-based interventions can vary widely, 123 
further complicating the evaluation process. For instance, session length, frequency of delivery and 124 
the topic of the disclosure can vary. Emotional disclosure-based interventions also go beyond 125 
expressive writing and can include, for example, spoken disclosure (33), poetry (34) and narrative 126 
therapy (35). There is often overlap between types of intervention (for example, written and spoken 127 
forms) and the language used to describe them. It is therefore challenging to understand which, if any, 128 
intervention components may potentially be most effective. To our knowledge, no review to date has 129 
explored the range of emotional disclosure-based interventions tested in palliative populations.   130 
In summary, emotional disclosure-based interventions still appear to hold therapeutic potential for 131 
people with advanced disease. A lack of clarity on which emotional disclosure-based intervention 132 
characteristics may be optimal, their mechanisms of action and appropriate outcome measures, may 133 
limit our current understanding of  how such interventions may be beneficial for palliative populations 134 
(26,36). This scoping review therefore aims to derive a greater understanding of the range of 135 
emotional disclosure-based interventions evaluated in palliative populations, looking beyond 136 
expressive writing, and to understand what a potentially effective one may look like.   137 
The objectives of the review are to: 138 
1. Develop a taxonomy of emotional disclosure-based interventions used for people with 139 
advanced disease. The taxonomy will identify, categorise and define classes (i.e., types) of 140 
intervention that fall under the umbrella term ‘emotional disclosure’. 141 
 142 
2. Map and identify any potential links between intervention characteristics, objectives, 143 
outcome measures, underlying mechanisms, facilitators and barriers and efficacy of 144 





A scoping review is a suitable method for mapping out complex literature bases in a systematic 148 
manner (37). This review was conducted in six key stages, guided by standard scoping review 149 
frameworks (38–40). The protocol guiding this scoping review is reported elsewhere (41). In line with 150 
the iterative nature of scoping reviews, the protocol has been updated throughout the process, as 151 
documented in Supplementary File 1. 152 
 153 
Stage 1. Defining the research question 154 
The following research questions were defined: 155 
1. Which psychotherapeutic interventions for patients with advanced disease are categorised as, or 156 
explicitly grounded in, emotional disclosure?  157 
2. What are the primary objectives and characteristics of emotional disclosure-based interventions 158 
evaluated in this population?  159 
3. What outcome measures are used to assess the efficacy of emotional disclosure-based 160 
interventions in this setting, and which of these captured significant effects? 161 
4. What theoretical frameworks are used to explain the mechanisms underlying emotional 162 
disclosure-based interventions in this setting? 163 
5. What are the facilitators and barriers to feasibility and efficacy of emotional disclosure-based 164 
interventions in this setting? 165 
 166 
Stage 2. Identifying relevant studies 167 
Eligibility criteria 168 
All primary studies (irrespective of design) of emotional disclosure-based psychotherapeutic 169 
interventions were included, provided they: 170 
a. Described the method of at least one task or exercise as part of the intervention that is 171 
designed to encourage or facilitate the disclosure, expression or discussion of emotions or 172 
feelings AND 173 
b. Described emotional disclosure or expression of emotions as a key goal, rationale or 174 
functional mechanism of the intervention 175 
Only studies testing interventions with adults (aged 18 and above) with a diagnosis of an advanced 176 
disease, such as metastatic cancer (or characterised as Stage III and/or IV), and/or being explicitly 177 
treated with a palliative intent were included. Advanced disease is a broad and commonly used term 178 
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selected to capture the broad range of diagnoses that could fall under the remit of palliative care. 179 
Samples which included >50% patients with advanced disease were also included. 180 
 181 
Exclusion criteria 182 
Publications not in the English language, review articles, discussion pieces, book chapters and 183 
dissertations/theses were excluded. Music, art, life review, dignity and group therapies were excluded 184 
as distinct therapy types that have been reviewed elsewhere (42–48).  185 
 186 
Databases 187 
Six databases were searched from inception to May 2020: CINAHL, Cochrane Central Register of 188 
Controlled Trials (CENTRAL), PsycINFO, Scopus, Web of Science and MEDLINE. The European Union 189 
Clinical Trials Register, clinicaltrials.gov, the European Association for Palliative Care conference 190 
abstracts for the last seven years (2012–2019) and reference lists of relevant studies, review articles, 191 
book chapters and theses were also checked. 192 
 193 
Search strategy 194 
A combination of Medical Subject Headings (MeSH) and free-text search terms for emotional 195 
disclosure, advanced disease and palliative care were used. The terms for emotional disclosure were 196 
based on earlier, related reviews, but adapted to capture a range of disclosure formats (22,24). The 197 
terms for advanced disease and palliative care were based on a previous review (24), recommended 198 
by the Cochrane Palliative Care research group. An example of the search strategy string used for the 199 
Ovid PsycINFO database is shown in Table 1. The string was optimised for each database (see 200 
Supplementary File 2). 201 
 202 
Stage 3. Study selection 203 
Two reviewers independently screened titles and abstracts for inclusion to the full article review stage. 204 
Full article review was also conducted independently by two researchers. Unclear decisions were 205 
discussed between members of the review team. 206 
 207 
Stage 4. Charting the data 208 
A data extraction form was developed based on the variables most relevant to the research questions 209 
(see Supplementary File 3). Extraction was completed by one author and a sample of five studies 210 




Stage 5. Collating, summarising and reporting the results 213 
Synthesis was based on Intervention Component Analysis, which is a pragmatic approach to 214 
identifying which characteristics of an intervention, from a group of similar interventions, are 215 
potentially important in terms of outcomes (49). Intervention Component Analysis  uses qualitative 216 
thematic techniques to analyse intervention descriptions to identify and group core characteristics of 217 
an intervention. Parallel to this, experience-based evidence from study methods and discussion 218 
sections is thematically analysed; this evidence captures authors’ descriptions of their experience 219 
developing and implementing the intervention. Whilst Intervention Component Analysis is designed 220 
to review interventions reported in trials that aim to influence the same outcome, this scoping review 221 
includes a range of study designs using a number of outcome measures. The principles of Intervention 222 
Component Analysis were therefore used but the approach was modified to suit the available 223 
evidence and meet the review objectives.  224 
After extracting intervention descriptions, through iterative comparison and discussion, three 225 
operative domains were identified (i.e., overarching categories within which interventions varied). 226 
These were used as a framework for further exploration. Firstly, to form a multi-level taxonomy; using 227 
thematic analysis intervention descriptions were coded and similar characteristics grouped into 228 
classes (i.e., types) within each of the identified domains (Figure 2). Intervention objectives were then 229 
coded and grouped, and these were mapped to the outcome measures being used to assess them 230 
(Table 3). Thirdly, intervention classes in the multi-level taxonomy were mapped to the reported 231 
efficacy of interventions within them (Table 4). The underlying mechanisms that studies proposed 232 
were then grouped into theoretical classes (Table 5). Finally, in parallel to these processes, the 233 
facilitators and barriers extracted from discussion sections and methodological descriptions were 234 
analysed using thematic analysis (Figure 3). One author (DM) led the analysis, with themes and 235 
conclusions discussed with the research team and updated throughout.  236 
Quality appraisal 237 
Study quality was graded by one author using the Hawker tool (50) and a subset of five was checked 238 
by another. Differences were resolved through discussion, and scoring amended as appropriate. In 239 
line with the grading used in prior reviews, scores ≤18 are rated ‘poor’, scores from 19-27 ‘fair’ and 240 
≥28 ‘good’ (51). Quality appraisal is not a required component of scoping review methodology (40). 241 
However, as one objective of this review was to map intervention characteristics to their reported 242 
efficacy, we recognised a value in assessing the quality of included studies to gauge the reliability of 243 
any links drawn from them. 244 
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Stage 6. Consultation 245 
The scoping review was conducted collaboratively at all stages with the core research team, involving 246 
a palliative care consultant, a psychiatrist, health psychologist and researchers with expertise in 247 
emotional disclosure, palliative care research and systematic reviewing. Clinical psychologists and a 248 
Patient and Public Involvement (PPI) representative were also consulted at key points.  249 
 250 
Results 251 
Characteristics of included studies 252 
The literature search identified 7,792 unique citations. Of these, 25 primary studies reported in 32 253 
papers met the inclusion criteria (17 RCTs, three other studies reporting preliminary, secondary or 254 
qualitative analyses of data from RCTs, and five other studies of different designs). Figure 1 presents 255 
a PRISMA flow diagram of study selection. Of the five studies using different designs (52–56), three 256 
used qualitative methods (52–54) of which two were case studies (52,53); and two used mixed 257 
methods (55,56). Studies were conducted in four countries: USA (n=18), UK (n=5), China (n=1) and 258 
Uruguay (n=1). Most studies tested the intervention in people with advanced or incurable cancer 259 
(n=19); other populations were people with amyotrophic lateral sclerosis (ALS) (n=2), end stage renal 260 
disease (ESRD) (n=1) and mixed terminal diagnoses (n=3).  261 
Population and intervention characteristics are detailed in Table 2. More detailed study summaries 262 
are reported in Supplementary File 4. 263 
Quality appraisal 264 
Of the 32 included papers, 20 were rated as ‘Good’ and 10 as ‘Fair’; two were not in appropriate 265 
formats for quality appraisal (one protocol and one abstract). Supplementary File 5 presents a 266 
summary of ratings. 267 
Multi-level taxonomy of emotional disclosure-based interventions  268 
A multi-level taxonomy of emotional disclosure-based interventions is presented in Figure 2. Through 269 
iterative discussion and comparison, topic of disclosure, format of disclosure and dose were identified 270 
as operative domains. Classes are proposed within each domain.  271 
Primary objectives and outcome measures 272 
Intervention objectives were grouped into the following classes (see Table 3): quality of life, care 273 
quality and access, psychological wellbeing, physical wellbeing, existential and spiritual wellbeing, 274 
sleep and fatigue, and interpersonal. In cases where studies did not explicitly state primary 275 
intervention objectives, the stated aim of the study was used. Classes were then mapped to study 276 
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primary outcome measures. The most commonly explored class of primary objective (in 14 of 17 RCTs) 277 
was psychological wellbeing. Within that class, objectives and outcome measures varied, including a 278 
range of anxiety, depression and overall distress measures. Across the studies, 41 different outcome 279 
measures were used to evaluate primary intervention objectives, and follow-up time-points ranged 280 
from immediately to 18 months post-intervention.  281 
Significant positive effects were reported in RCTs for 17 different outcome measures (summarised in 282 
Table 4); at least one measure within each objective class reported a significant positive effect. 283 
However, results using each measure were not consistent across studies. Results are described as 284 
“effective” based on statistical significance, although it is recognised that this is limited in that it 285 
provides no indication of study quality or effect size. However, what is sought is consistency in findings 286 
across studies to guide the direction of future research, rather than making clinical recommendations. 287 
All study results are summarised in Supplementary File 4. 288 
Mapping intervention classes to efficacy 289 
Table 4 shows the mapping of classes within each domain in the taxonomy to study outcomes. 290 
Topic of disclosure 291 
In the majority of studies, participants were directed to express their feelings about their illness as at 292 
least one of the disclosure topics (n=14). Of these, nine were trials, of which six reported significant 293 
positive effects on at least one outcome compared to control, including accessing mental health 294 
services (57), psychological wellbeing (33,58,59), quality of life (60), sleep (61), physical symptoms (61) 295 
and interpersonal relationships (62). One RCT reported a significant negative effect of the intervention 296 
which directed people to express emotions about their illness (58). This found that there was a 297 
significant interaction between time since diagnosis and group: women in the intervention group with 298 
a longer time since diagnosis were more likely to report increased sleep disturbances at three months 299 
follow-up compared to those in the control group. 300 
Six trials investigated interventions using general trauma or negative experiences as at least one of 301 
the disclosure topics. Of these, studies reported a significant improvement in existential and spiritual 302 
wellbeing (63), pain (64), depressive symptoms and anxiety (65) compared to control. Two did not find 303 
any significant effects on any measure (although they were not powered to do so) (25,66). Some 304 
interventions also asked people to express feelings on growth, ways of coping or positive emotions. 305 
Of these, significant positive effects versus control were reported on measures of quality of life 306 
(60,67), psychological wellbeing (35,67,68), physical wellbeing (64) and existential wellbeing (63), as 307 
well as interpersonal relationships (67). Most interventions asked participants to express feelings 308 
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about a combination of different topics. In sum, no single topic or combination of topics was 309 
consistently related to a positive effect on any particular outcome. 310 
Format of disclosure 311 
Most studies (n=15) investigated interventions asking people to express thoughts and feelings through 312 
spoken disclosure (35,52–56,59,62,63,67–78). Eight studies investigated written disclosure 313 
(57,58,60,61,65,66,79,80). Two studies explored flexible interventions, which gave participants the 314 
option of whether to speak or write (25,33). Table 2 gives a description of the nature of these 315 
interventions. 316 
RCTs testing spoken interventions reported significant effects on quality of life (67), depression (35), 317 
cancer-related distress (68), pain (64), self-compassion (67), existential/spiritual wellbeing (63) and 318 
interpersonal relationships (62,67). Five RCTs investigating written interventions also reported 319 
significant effects compared to control on anxiety (65), sleep (61), uptake of mental health services 320 
(57), intrusive thoughts (58), somatic symptoms (58), and quality of life (60). Of the two RCTs that 321 
investigated a flexible intervention, one reported a significant improvement in psychological wellbeing 322 
three months post-intervention (33). The other was a feasibility study not designed to evaluate 323 
efficacy (25). In sum, there were no obvious patterns: all formats resulted in benefits in some 324 
outcomes. 325 
Dose of disclosure 326 
The majority of studies (n=19) investigated short-term interventions (classified as 2-8 sessions) 327 
delivered over a time period of up to two months (33,53,56–63,65–68,72,73,76,79–81). Four studies 328 
investigated one-off interventions, two of which were RCTs that reported significant improvements in 329 
the emotional disclosure group compared to control (one on pain and one on depression) (35,64). The 330 
other two studies (one case study, and one that did not report on efficacy) investigated longer term 331 
interventions delivered on an ongoing weekly or monthly basis and no defined number of sessions 332 
(52,69–71). Session length as well as the interval between sessions varied considerably (see Table 2). 333 
In sum, no links could be made between intervention dose and effectiveness. However, some studies 334 
did suggest that for interventions linking emotional processing and awareness to outcomes, more 335 
sessions over a longer time period may be needed to produce long-term effects (59,77,78). 336 
Overview of underlying mechanisms 337 
The theories and models used to inform intervention development and explain potential effects are 338 
summarised in Table 5. Studies drew on a range of communication, social, psychoanalytic, cognitive, 339 
developmental and self-compassion theories, but rarely provided a full theoretical justification for 340 
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each intervention characteristic. One found that low levels of emotional support and more recent 341 
diagnoses were associated with better responses to the intervention (58). Another found that 342 
emotional disclosure increased quality of life only if illness-related couples’ communication also 343 
improved (60). Studies reported contrasting findings relating to the role of natural expressivity. One 344 
study found high levels of baseline emotional expressivity were associated with a larger effect on 345 
depressive symptoms (59). Others found high levels of holding back (62), and ambivalence over 346 
emotional expression (33) were associated with larger effects. In sum, a number of studies 347 
investigated moderators of intervention effects to explore underlying mechanisms, with overall mixed 348 
findings.  349 
Facilitators and barriers to feasibility and efficacy 350 
This section reports the results of the thematic analysis of experience-based evidence where authors 351 
discuss their findings in relation to their intervention design and implementation. We identified five 352 
inter-related themes as important factors to consider in development of emotional disclosure-based 353 
interventions for palliative populations. These are summarised in Figure 3 and described below. 354 
Impact of disease stage and type  355 
Whilst all studies recruited people with advanced disease, the stage ranged from pre-palliative (63) to 356 
people receiving inpatient hospice care with less than six months to live (53,72,73). Participant health 357 
was often noted by authors as a factor limiting recruitment, retention and adherence (25,33,35,55,60–358 
62,64,66,72,73,82). Some suggested that emotional disclosure-based interventions may be more 359 
suitable for people at the earlier stages of advanced illness, as they may be more physically able to 360 
complete the intervention (25,66,72,73). Some study authors also suggested that emotional 361 
disclosure-based interventions may be more suitable for people who have not yet processed the 362 
trauma they are being asked to disclose; for example, those who had been relatively recently 363 
diagnosed (58), who had experienced an acute stressor (33,57), or who had exhibited higher baseline 364 
levels of distress (57,61,63). However, others noted that short-term emotional disclosure-based 365 
interventions may not produce enduring effects due to the evolving nature of advanced illness, 366 
suggesting booster sessions as a possible solution (76). And others suggested that the increased 367 
patient contact for people at an advanced stage of illness may in fact increase retention compared to 368 
those at an earlier stage of disease (65). 369 
Ensuring a safe environment for disclosure 370 
The importance of creating an environment where people feel comfortable to share difficult feelings 371 
was frequently highlighted (25,53–55,76,79,83). This related to the physical environment; for 372 
example, setting the intervention in a safe space, such as the participant’s home, or a private room 373 
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(81). It also referred to contextual factors, such as incorporating other soothing or positive elements 374 
that facilitate feelings of comfort (53,55) and healthcare professionals endorsing the intervention and 375 
framing it as safe and trustworthy (54). The importance of creating a safe environment extended to 376 
ensuring that family carers felt comfortable with the participant taking part in the intervention (33,55); 377 
this can be particularly salient in non-Western countries, such as China, where there are cultural 378 
barriers to expressing emotions (53). Some noted that partner-based interventions improved 379 
retention and feasibility over private interventions (62,67), suggesting the presence of a partner may 380 
contribute to feeling safe and supported. However, challenges associated with dyads were also 381 
reported, such as inhibitions around disclosing emotions to a partner or worry about burdening them 382 
(62). 383 
Flexibility of intervention  384 
Flexibility in format and delivery was often noted as a facilitator. This is partially related to the variable 385 
health of participants and location of where people were receiving care; where expression sessions 386 
were held at structured times and places, participants were often not able to attend or complete the 387 
intervention due to illness or other appointments (25,63). Likewise, if the intervention was only 388 
delivered in a specific room at the hospice, it became less accessible for people who were unable to 389 
leave their home, or bed (25,55,66). The place where people feel most safe to disclose their emotions 390 
can also vary between individuals; thus it is important to provide flexibility about the intervention 391 
location (25). Likewise, authors noted that there were individual differences in the format with which 392 
people felt comfortable disclosing their emotions, related to factors such as stage of disease (33,52), 393 
differences in education, or simply personal preference (25,54,66). 394 
Clarity and structure of instructions 395 
A number of authors commented on clarity of instructions as an important factor in ensuring 396 
adherence to the core expressive components of the intervention, particularly for self-directed 397 
interventions (33,58,63,66). In one study it was noted that despite instructions asking participants to 398 
focus on their feelings, the tendency was to describe a factual account of their illness journey, 399 
undermining the emotional expression objective of the intervention (66). Whilst a certain amount of 400 
structure and guidance on disclosure topics was highlighted as important, opportunity to move 401 
beyond the prompts and experience self-revelation was also highlighted as valuable (53,63). Another 402 
study highlighted that interventions with an unstructured format may be better suited to those with 403 
higher baseline emotional expressivity (59). It was also suggested that building in additional supportive 404 
components, such as coping skills training, may help to optimally manage distress (59,76). 405 
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Staff engagement and training 406 
The importance of staff endorsement to build trust, staff knowledge and management support were 407 
noted as key for successful implementation (54,55,82). Providing staff with information about the 408 
intervention was also noted to help allay their fears around how to respond to patients bringing up 409 
emotional concerns (54,69). Others highlighted that when delivering the intervention in the palliative 410 
care unit or hospice, there were interruptions from staff, and that there could be difficulties in finding 411 
an appropriate space, which may require management support (27,30). Finally, one study noted the 412 
importance of clear communication during the consent process, as some participants declined taking 413 
part because they did not feel entitled to further treatment for their mental wellbeing, since they were 414 
already receiving holistic care from their hospice team (35). 415 
Discussion 416 
Main findings 417 
This scoping review developed a multi-level taxonomy, grouping emotional disclosure-based 418 
interventions for people with advanced disease into three operative domains: topic, format and dose 419 
of disclosure. Within each domain, intervention characteristics were grouped into classes, and each 420 
class mapped to reported efficacy. An earlier systematic review already showed that the overall 421 
evidence of expressive writing efficacy is mixed (24). The present review unpicked a broader range of 422 
emotional disclosure-based interventions to determine if there is any indication of which 423 
characteristic, or combination of characteristics, may hold the most therapeutic potential. Whilst 424 
there were no clear patterns in terms of which intervention characteristics in any domain were most 425 
effective, it was possible to identify a framework of potential key characteristics to guide further 426 
research. 427 
Objectives and outcome measures 428 
The objectives of emotional disclosure-based interventions varied, and included improvement of 429 
quality of life, as well as psychological, physical and existential wellbeing. Most studies described the 430 
improvement of some aspect of psychological wellbeing as a primary objective. Many, though, 431 
provided vague descriptions of objectives. A range of outcome measures were employed to evaluate 432 
intervention efficacy, and follow-up time-points also varied. This reflects the uncertainty within the 433 
emotional disclosure and psychological intervention literature as a whole, on how best to evaluate 434 
such interventions (30,84). That said, these are holistic interventions and thereby impact is likely to 435 
be broad in terms of benefit. 436 
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Theoretical mechanisms 437 
Authors drew on a wide range of psychological and social theories to inform and explain emotional 438 
disclosure-based intervention development and effect; this is similar to other reviews (29–31). 439 
However, these were rarely fully developed into causal mechanisms. Medical Research Council 440 
guidelines suggest that effective intervention development should be based on a clear understanding 441 
of its causal mechanisms (26,36). As emotional disclosure-based interventions vary across a number 442 
of domains, a single, cohesive theoretical framework to fit all emotional disclosure-based 443 
interventions is unlikely to be suitable. Rather, when developing interventions, researchers should 444 
focus on proposing theoretical accounts to justify the intervention design. Some studies in this review 445 
harnessed the potential of qualitative or linguistic analysis of disclosure texts to explore underlying 446 
mechanisms (25,55,77–80,83); this represents a potentially fruitful direction for future research. Such 447 
theoretical work can in turn inform appropriate outcome measure selection. In line with the wider 448 
psychosocial intervention literature (85), findings highlight that there are likely to be individual 449 
differences in response to emotional disclosure. Clarifying the underlying mechanisms and individual 450 
differences in response to emotional disclosure-based intervention will ultimately help clinicians to 451 
decide which, if any, forms of emotional disclosure-based interventions are likely to work for which 452 
people.  453 
Facilitators and barriers 454 
The review identified five themes relating to facilitators of and barriers to emotional disclosure-based 455 
intervention implementation and efficacy: impact of disease stage; ensuring a safe environment; 456 
flexibility; clarity and structure of instructions; and staff engagement and training. When developing 457 
interventions for people with advanced disease, it is crucial to understand the specific environment 458 
where these interventions will be implemented, and to adjust them accordingly (26,36). Unless an 459 
intervention can be effectively implemented, it will not be effective on a wide scale. As such, it is 460 
recommended that future research developing emotional disclosure-based interventions for the 461 
palliative care setting should pay attention to the themes highlighted here, in combination with 462 
appropriate co-design work to develop practically implementable interventions (86). 463 
Strengths and limitations 464 
A systematic, six-stage process based on scoping review guidelines was undertaken to capture and 465 
map a broad body of literature. This review applied a pragmatic, novel approach (modified 466 
Intervention Component Analysis) to synthesise insights into intervention characteristics, evaluation 467 
approaches, theoretical frameworks and implementation factors, including studies that used a range 468 
of study designs. By including studies that were not designed to assess efficacy (such as feasibility and 469 
pilot studies), it was also possible to capture information about acceptability and feasibility. However, 470 
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this limited the possibility of drawing clear links between intervention characteristics and efficacy. 471 
Regardless of this decision, the heterogeneity of intervention objectives and outcome measures made 472 
efficacy synthesis challenging. In light of this, one core strength of the review was the capture and 473 
analysis of experience-based evidence. This provided important insights into key implementation 474 
factors that should be considered in the design of interventions, but which are often overlooked in 475 
more traditional evidence syntheses. As all papers were graded as ‘Good’ or ‘Fair’ quality, this lends a 476 
certain degree of credibility to this evidence. However, due caution should still be applied when 477 
considering its strength since much of this data is based on informal author reflections. 478 
Studies evaluated interventions in a range of palliative settings and populations. This strengthens the 479 
generalisability and relevance of findings to palliative care services, which usually provide care for 480 
people with a range of diagnoses. However, whilst people living with advanced disease do share 481 
common experiences, some physical and psychological challenges are uniquely associated with 482 
specific conditions. Should researchers use insights from this review to inform intervention 483 
development, it would be important to consult with relevant stakeholders to ensure they address 484 
population and setting-specific factors on a more granular level. The majority of included studies were 485 
conducted in Western countries (US and UK). There can be significant cultural differences in the ways 486 
death, disease and emotional expression are viewed (15,87). It is critical researchers consider this 487 
when interpreting or applying the results of this review in non-Western countries, or areas with multi-488 
cultural populations. 489 
Since emotional disclosure is a component of many formats of psychological therapy, there was 490 
sometimes a lack of clarity over what constitutes an emotional disclosure-based intervention. Despite 491 
employing a rigorous, discursive process to determine eligibility, some level of subjectivity about the 492 
selection of papers remained. However, the review was not designed to exhaustively capture every 493 
study that has ever been conducted in the field. Rather, it was designed to identify different types of 494 
intervention that could be classified as ‘emotional disclosure-based’, to systematically assess their 495 
characteristics and to identify the reasons why they may or may not be effective in palliative 496 
populations. 497 
What this review adds 498 
This review maps the range of emotional disclosure-based interventions tested in people with 499 
advanced disease and proposes a multi-level taxonomy classifying their core characteristics. This is 500 
important as these low-cost interventions have therapeutic potential in palliative care settings. The 501 
review could help researchers adopt a common language to describe emotional disclosure-based 502 
interventions for people with advanced disease (and perhaps beyond) and inform design of future 503 
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research, including systematic reviews and meta-analyses. This paper describes paths for researchers 504 
to move forward with the development of interventions that can be practically implemented, drawing 505 
on key facilitators and barriers. It also provides recommendations into promising avenues for future 506 
intervention evaluation to help guide selection of appropriate outcome measures. Additionally, the 507 
paper acts as an exemplar of a review approach that may be used to inform development and 508 
evaluation of complex, multi-component interventions where pre-existing evidence is mixed. 509 
Conclusion 510 
Based on a systematic scoping of a diverse literature, this review has mapped and drawn links between 511 
emotional disclosure-based intervention characteristics, objectives, outcome measures, efficacy and 512 
implementation factors. By drawing on the Intervention Component Analysis method, it was possible 513 
to integrate information not usually considered in traditional reviews of intervention efficacy. This has 514 
allowed the proposal of novel evidence-based recommendations for future research aiming to 515 
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